Your browser doesn't support javascript.
loading
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens.
Xu, Mingxuan; Tapia, Coya; Hajjar, Joud; Sabir, Sharjeel; Colen, Rivka; Nagarajan, Priyadharsini; Aung, Phyu P; Gong, Jing; Rodon, Jordi; Fu, Siqing; Stephen, Bettzy; Roy-Chowdhuri, Sinchita; Le, Hung; Yang, Vincent; Zarifa, Abdulrazzak; Abdelsalam, Mohamed Elsayed; Jhingran, Anuja; Javle, Milind; Pant, Shubham; Carter, Brett; Milton, Denai R; Sun, Ryan; Karp, Daniel D; Koay, Eugene Jon; Yang, Yali; Wistuba, Ignacio I; Hwu, Patrick; Meric-Bernstam, Funda; Naing, Aung.
Afiliación
  • Xu M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tapia C; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hajjar J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sabir S; Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Colen R; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nagarajan P; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gong J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stephen B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roy-Chowdhuri S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Le H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zarifa A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Abdelsalam ME; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jhingran A; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Javle M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carter B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Milton DR; Section of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Karp DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Koay EJ; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wistuba II; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hwu P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meric-Bernstam F; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Immunother Precis Oncol ; 4(2): 45-52, 2021 May.
Article en En | MEDLINE | ID: mdl-35663531
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Immunother Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Immunother Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos